Hot Searches: Color Doppler Ultrasound Probe Puncture Rack
scroll down
Latest Products
Rencheng Company 2020 Spring Festival Holiday Notice
2020-01-19
As the 2020 Spring Festival approaches, in accordance with the "State Council's General Office Announcement on the 2020 Spring Festival Holiday Arrangements," and considering the company's actual situation and work arrangements, the 2020 Spring Festival holiday schedule is as follows:
Spring Festival Holiday: January 22, 2020 to January 31, 2020, a total of 10 days off. Work resumes on February 1, 2020 (the eighth day of the lunar new year).
On the occasion of the 2020 Spring Festival holiday, we would like to express our gratitude for your continued support and kindness. We extend our holiday greetings to you and wish you a Happy New Year, prosperity, a harmonious family, and happiness for all.
Kindly Note: During the holiday, the company will suspend repairs and shipping.
2020-01-17
Looking back at 2019, the capital winter continued to spread, and it wasn't just institutional investors who were more cautious about spending; internet giants also seemed to be considering investment returns. According to Lianxian Insight data, in the first half of 2019, Tencent's new acquisitions of affiliated companies and increased investments in existing affiliated companies totaled 8.459 billion yuan, while the figure for the same period last year was 31.976 billion yuan. Spending money wisely and rationally became the true portrayal of these giants this year. Against this backdrop, how are internet giants deploying their forces in the trillion-yuan medical market, where they have already established a presence and engaged in fierce competition?
2020-01-16
News of the approval and market launch of Co-Asia Medical's 'Coronary Blood Flow Reserve Fraction Calculation Software Product' by the National Medical Products Administration (NMPA) last night sent shockwaves through the industry. Compared to well-known star projects like those from companies such as Tech, Deepwise Medical, Sukon Technology, and Silicon-based Intelligence, Co-Asia Medical is relatively unknown. This unexpected win of the first domestic Class III certificate for a deep learning AI product is surprising. Co-Asia Medical claims this is China's first AI-powered Class III medical device to pass regulatory review. The approval of this AI-powered Class III medical device marks a milestone event for the medical AI industry.
Shanghai Issues Report on Special Inspection of Third-Party Medical Device Logistics Companies
2020-01-15
China Quality News Network reported on January 14, 2020, that the Shanghai Municipal Drug Supervision Administration announced on its website that in order to strengthen the supervision of third-party medical device logistics enterprises in the city, implement the main responsibility of enterprises, and urge enterprises to legally and compliantly carry out medical device storage and distribution services, the bureau organized a special inspection of some third-party medical device logistics enterprises in the fourth quarter. I. Inspection arrangements and priorities This special inspection was carried out on 20 third-party logistics enterprises that hold the city's "Medical Device Business License" and whose business scope is "Providing storage and distribution services for other medical device manufacturers and operators".
Medical device representative, we need you
2020-01-13
If 2009, the "first year of deepening medical reform," was still an infant in swaddling clothes, then ten years later, in 2019, "deepening medical reform" was like the spring described by Zhu Ziqing, joyfully opening its eyes and running, with every inch of land touched by sunlight continuing the cycle of withering, flourishing, and decay. But when it trembled slightly, it completely changed our original lives, like the collapse of medicines in the "earthquake" of volume-based procurement, the irreversible consistency evaluation, and the disappearance of pharmaceutical companies and representatives. ▍Is the pharmaceutical industry still worth working in? Current Situation: Over the past 40 years, the pharmaceutical industry has grown from 7.28 billion yuan in total industrial output value nationwide in 1978
2020-01-10
Shanghai, January 10, 2020 /PRNewswire/ -- On January 9, at the 12th Health China Forum hosted by People's Daily Health Client and Health Times, Philips Lumify portable ultrasound diagnostic system won the 2019 "Top Ten Medical Devices" award. The Philips Lumify portable ultrasound diagnostic system integrates hardware, software and service innovation, not only providing professional high-definition imaging, but also providing remote diagnostic experiences for doctors and patients through convenient remote connections, thereby breaking the limitations of space and personnel. The Health China Annual Forum is China's pharmaceutical and health
Chinese high-end medical device companies achieve a new level of innovation
2020-01-08
The development of medical devices in China encapsulates nearly a century of medical advancements. Although China's start in the innovation and R&D of medical devices was relatively late, and there's a lack of accumulation in basic research. Achieving a breakthrough from zero to one requires the accumulation of time, experience, and knowledge. Dr. He Qiong, Chief Scientist of Haisco, a graduate of Tsinghua University, stated: "In the process of accumulation, we have always cultivated innovative 'soil', vigorously promoted technological transformation, successfully 'cultivated' a new generation of non-invasive liver disease detection technology, and launched the new Brand iLivTouch, providing impetus to the high-quality development of China's medical device industry."
Contact Us
Room 618, 36 Gaoke Road, Tianhe District, Guangzhou, China
national unified free service hotline:400-020-6788
Copyright©2025 All Rights Reserved of Rencheng (Guangzhou) Medical Equipment Maintenance Co., Ltd.
